Novozymes A/S (NVZMY) to Release Quarterly Earnings on Thursday

Novozymes A/S (OTCMKTS:NVZMY) will likely be announcing its resultson Thursday, May 14th. Analysts expect the company to announce earnings of $0.8160 per share and revenue of $1.3230 billion for the quarter.

Novozymes A/S (OTCMKTS:NVZMY) last announced its earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.31). The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. Novozymes A/S had a net margin of 14.22% and a return on equity of 6.57%. On average, analysts expect Novozymes A/S to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Novozymes A/S Trading Down 0.9%

Novozymes A/S stock opened at $59.15 on Tuesday. The firm has a market cap of $24.52 billion, a price-to-earnings ratio of 39.97, a price-to-earnings-growth ratio of 1.12 and a beta of 0.98. Novozymes A/S has a 1 year low of $49.90 and a 1 year high of $75.99. The firm’s 50 day moving average price is $58.31 and its two-hundred day moving average price is $61.03. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.44 and a current ratio of 0.72.

Analysts Set New Price Targets

NVZMY has been the subject of a number of research analyst reports. Rothschild & Co Redburn upgraded Novozymes A/S to a “strong-buy” rating in a report on Friday, March 27th. Zacks Research downgraded Novozymes A/S from a “hold” rating to a “strong sell” rating in a report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).